U.S. flag

An official website of the United States government

GRCh37/hg19 4p16.3(chr4:68345-1675143)x1 AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 1, 2021
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001834475.1

Allele description [Variation Report for GRCh37/hg19 4p16.3(chr4:68345-1675143)x1]

GRCh37/hg19 4p16.3(chr4:68345-1675143)x1

Genes:
Variant type:
copy number loss
Cytogenetic location:
4p16.3
Genomic location:
Chr4: 68345 - 1675143 (on Assembly GRCh37)
Preferred name:
GRCh37/hg19 4p16.3(chr4:68345-1675143)x1
HGVS:
NC_000004.11:g.(?_68345)_(1675143_?)del

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002095739Quest Diagnostics Nichols Institute San Juan Capistrano
no assertion criteria provided
Pathogenic
(Feb 1, 2021)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV002095739.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This terminal deletion of 4p16.3 is associated with Wolf-Hirschhorn syndrome (WHS), a contiguous gene deletion syndrome associated with a hemizygous deletion of chromosome 4p16.3 (OMIM #194190). It is characterized by typical craniofacial features in infancy consisting of "Greek warrior helmet" appearance of the nose, microcephaly, high anterior hairline with prominent glabella, widely spaced eyes, epicanthus, highly arched eyebrows, short philtrum, downturned corners of the mouth, micrognathia, and poorly formed ears with pits/tags. All affected individuals have prenatal-onset growth deficiency followed by postnatal growth retardation and hypotonia with muscle underdevelopment. Developmental delay/intellectual disability of variable degree is present in all. Seizures occur in 90% to 100% of children with WHS. Other findings include skeletal anomalies (60%-70%), congenital heart defects (~50%), hearing loss (mostly conductive) (>40%), urinary tract malformations (25%), and structural brain abnormalities (33%). Although WHSC1/NSD2 and LETM1 are typically deleted in WHS, deletion of additional genes is likely required for the full expression of the phenotype. About 40%-45% have an unbalanced translocation with both a deletion of 4p and a partial trisomy of a different chromosome arm. These unbalanced translocations may be de novo or inherited from a parent with a balanced rearrangement. (Battaglia et al., GeneReviews. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1183/; Paradowska-Stolarz Adv Clin Exp Med. 2014 May-Jun;23(3):485-9. PMID: 24979523).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 11, 2022